Cambridge research laboratory Draper has signed a deal with Bristol-Myers Squibb to develop a version of their organ-replicating chip specifically for the pharmaceutical giant to use in testing its liver disease drugs. 

The laboratory will work with Bristol-Myers (NYSE: BMY) to develop a version of its PREDICT-96 human organ system that replicates the functions and stresses that a diseased liver can be subjected to. The system contains small chips onto which tissue from livers and other organs…

Boston Biz Journal https://www.bizjournals.com/boston/news/2019/06/27/draper-laboratory-signs-organ-on-chipdevelopment.html?ana=RSS&s=article_search